APTINYX INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Published: 2021-10-27 07:18:09 ET APTX

Item 8.01 Other Events.

On October 27, 2021, Aptinyx Inc. issued a press release titled "Aptinyx Completes Enrollment in Phase 2b Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy." A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.